Sign in
4

Changes in Ownership

Definium Therapeutics, Inc. Filed Acc 0001104659-24-132164

Chief Medical Officer sold 6,643 shares at $7.43 ($49,357)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Karlin Dan · Chief Medical Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-12-26 Sale : show line 1 in the form 10b5-1 −6,643 $7.43 $49,357 338,013 D
Open-market sales · 6,643 sh · avg $7.43 · $49,357
Loading xslF345X05/tm2432133-2_4seq1.xml…